Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

C-glycosyl flavone from Urginea indica inhibits proliferation & angiogenesis & induces apoptosis via cyclin-dependent kinase 6 in human breast, hepatic & colon cancer cell lines.

Bevara GB, Naveen Kumar AD, Koteshwaramma KL, Badana A, Kumari S, Malla RR.

Indian J Med Res. 2018 Feb;147(2):158-168. doi: 10.4103/ijmr.IJMR_51_16.

2.

Alisertib induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt/mTOR- and p38 MAPK-mediated pathways in human glioblastoma cells.

Liu Z, Wang F, Zhou ZW, Xia HC, Wang XY, Yang YX, He ZX, Sun T, Zhou SF.

Am J Transl Res. 2017 Mar 15;9(3):845-873. eCollection 2017.

3.

A novel microtubule inhibitor, MT3-037, causes cancer cell apoptosis by inducing mitotic arrest and interfering with microtubule dynamics.

Chang LC, Yu YL, Hsieh MT, Wang SH, Chou RH, Huang WC, Lin HY, Hung HY, Huang LJ, Kuo SC.

Am J Cancer Res. 2016 Mar 15;6(4):747-63. eCollection 2016.

4.

Folate-functionalized human serum albumin carrier for anticancer copper(II) complexes derived from natural plumbagin.

Gou Y, Zhang Z, Qi J, Liang S, Zhou Z, Yang F, Liang H.

J Inorg Biochem. 2015 Dec;153:13-22. doi: 10.1016/j.jinorgbio.2015.09.004. Epub 2015 Sep 14.

PMID:
26398432
5.

Identification of novel kinase inhibitors by targeting a kinase-related apoptotic protein-protein interaction network in HeLa cells.

Shi Z, An N, Lu BM, Zhou N, Yang SL, Zhang B, Li CY, Wang ZJ, Wang F, Wu CF, Bao JK.

Cell Prolif. 2014 Jun;47(3):219-30. doi: 10.1111/cpr.12098. Epub 2014 Mar 19.

PMID:
24645986
6.

Pharmacophore identification, docking and "in silico" screening for novel CDK1 inhibitors.

Dong X, Yan J, Du L, Wu P, Huang S, Liu T, Hu Y.

J Mol Graph Model. 2012 Jul;37:77-86. doi: 10.1016/j.jmgm.2012.04.003. Epub 2012 Apr 23.

PMID:
22622012
7.

Homology modeling, molecular dynamic simulation and docking studies of cyclin dependent kinase 1.

Zhang L, Zhu H, Wang Q, Fang H, Xu W, Li M.

J Mol Model. 2011 Feb;17(2):219-26. doi: 10.1007/s00894-010-0710-z. Epub 2010 Apr 26.

PMID:
20419498
8.

Pyrrolo[2,3-a]carbazoles as potential cyclin dependent kinase 1 (CDK1) Inhibitors. Synthesis, biological evaluation, and binding mode through docking simulations.

Fousteris MA, Papakyriakou A, Koutsourea A, Manioudaki M, Lampropoulou E, Papadimitriou E, Spyroulias GA, Nikolaropoulos SS.

J Med Chem. 2008 Feb 28;51(4):1048-52. doi: 10.1021/jm0700666. Epub 2008 Jan 31.

PMID:
18232654
9.

Choice of Plk1 docking partners during mitosis and cytokinesis is controlled by the activation state of Cdk1.

Neef R, Gruneberg U, Kopajtich R, Li X, Nigg EA, Sillje H, Barr FA.

Nat Cell Biol. 2007 Apr;9(4):436-44. Epub 2007 Mar 11.

PMID:
17351640
10.
11.

Cdc2/cyclin B1 interacts with and modulates inositol 1,4,5-trisphosphate receptor (type 1) functions.

Malathi K, Li X, Krizanova O, Ondrias K, Sperber K, Ablamunits V, Jayaraman T.

J Immunol. 2005 Nov 1;175(9):6205-10. Erratum in: J Immunol. 2005 Dec 15;175(12):8440.

12.

Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors.

Kuo GH, Wang A, Emanuel S, Deangelis A, Zhang R, Connolly PJ, Murray WV, Gruninger RH, Sechler J, Fuentes-Pesquera A, Johnson D, Middleton SA, Jolliffe L, Chen X.

J Med Chem. 2005 Mar 24;48(6):1886-900.

PMID:
15771433

Supplemental Content

Loading ...
Support Center